Title |
Biochemical Cure after Reoperations for Medullary Thyroid Carcinoma: A Meta-analysis
|
---|---|
Published in |
Annals of Surgical Oncology, September 2014
|
DOI | 10.1245/s10434-014-4102-y |
Pubmed ID | |
Authors |
Kathryn J. Rowland, Linda X. Jin, Jeffrey F. Moley |
Abstract |
Despite meticulous surgical techniques, calcitonin levels remain detectable in 40 % to 66 % of patients after initial surgery for medullary thyroid carcinoma (MTC), and the optimal surgical management for persistent or recurrent disease remains controversial. Previous studies suggest that biochemical cure, defined by normalization of postoperative calcitonin measurements, predicts disease-free survival. Reoperative approaches range from targeted removal of detectable disease to comprehensive compartment-oriented lymph node clearance. |
Mendeley readers
The data shown below were compiled from readership statistics for 23 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 23 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Other | 3 | 13% |
Student > Master | 3 | 13% |
Researcher | 3 | 13% |
Student > Doctoral Student | 2 | 9% |
Professor | 2 | 9% |
Other | 4 | 17% |
Unknown | 6 | 26% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 16 | 70% |
Biochemistry, Genetics and Molecular Biology | 1 | 4% |
Engineering | 1 | 4% |
Unknown | 5 | 22% |